MedPath

Comparison of 2 drugs for reducing hemodynamic response during Intubation

Phase 4
Not yet recruiting
Registration Number
CTRI/2025/04/085152
Lead Sponsor
Sardar Patel Medical College Bikaner Rajasthan
Brief Summary

Laryngoscopy and Intubation are a crucial part of general anaesthesia in a patient undergoing surgery. Sympathetic stimulation and catecholamine release while performing Laryngoscopy and Intubation leads to hemodynamic changes ,mainly Tachycardia and  Hypertension.

Many agents are in use for reducing these hemodynamic changes. We plan  to use Dexmedetomidine and Magnesium Sulphate in nebulised form, in 90 patients, ASA grade 1 and 2 undergoing elective surgery who need Endotracheal Intubation.

Our aim will be to compare the hemodynamic changes of these two drugs during Laryngoscopy and Intubation. We will also observe the side effects and complications if any.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

ASA Grade 1 and 2, Age 18-35 years, BMI less than 30, Mallampati grading 1 and 2, Patients undergoing elective surgeries requiring General Anaesthesia with Endotracheal Intubation.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the hemodynamic effects of Nebulised Dexmedetomidine and Nebulised Magnesium Sulphate on the patient during Laryngoscopy and Intubation.Before nebulisation, After nebulisation. | 2, 5, and 10 minutes following Intubation
Secondary Outcome Measures
NameTimeMethod
To observe any side effects and complications related to the drugs.Intraoperative, Up to 24 hours Post-operatively.

Trial Locations

Locations (1)

Sardar Patel Medical College, Bikaner, Rajasthan

🇮🇳

Bikaner, RAJASTHAN, India

Sardar Patel Medical College, Bikaner, Rajasthan
🇮🇳Bikaner, RAJASTHAN, India
Dr Asif P
Principal investigator
7025862867
drasifmuhammedp@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.